press information / news
Internationally Leading Diabetes Researchers Gather in Munich
Neuherberg, September 27, 2016. The 4th Helmholtz-Nature Medicine Diabetes Conference, which took place from 18-20 September 2016, once again met with a positive resonance among the leading researchers and young scientists in the field of diabetes research. Sir Stephen O’Rahilly of the University of Cambridge received the Helmholtz Diabetes Lecture Award.
The diabetes conference series, organized jointly by Helmholtz Zentrum München and Nature Medicine has established itself as an internationally unique top conference in diabetes research. Leading experts and aspiring young scientists present and discuss their research approaches and latest findings in a personal ambience with the goal of jointly developing new strategies to combat the widespread disease diabetes mellitus. Beta cell regeneration and replacement therapies were key themes of this year’s conference. On 18 September, the current Körber award winner Hans Clevers of the Hubrecht Institute Utrecht opened the Night Lecture entitled “Wnt, Tcf7l2 and enteroendocrine cells”.
Several prizes were awarded at the conference for excellent achievements in diabetes research. The Helmholtz Diabetes Lecture honors outstanding achievements of a leading scientist and was held this year by Sir Stephen O’Rahilly of the University of Cambridge. The topic was the genetic causes of metabolic diseases. This year’s Novo Nordisk Helmholtz Young Investigator in Diabetes (HeIDi) Award for young scientists went to Zachary Knight of the University of California, San Francisco and Andrew Pospisilik of the Max Planck Institute of Immunobiology and Epigenetics, Freiburg. Vera Nies of the University of Groningen and Alexander Häusl of the Max Planck Institute of Psychiatry, Munich, won the Nature Reviews Endocrinology Abstract Prize for the best submitted abstracts.
Prof. Matthias Tschöp, director of the Helmholtz Diabetes Center (HDC) at Helmholtz Zentrum München and organizer of the conference, was very pleased with how things went at the fully booked event. He said, “We’re pleased that our event is such a magnet for top scientists year after year! This confirms our concept. The familial atmosphere of the conference lays the cornerstone for optimal networking and meaningful cooperation in the fight against diabetes.”
As German Center for Environmental Health, Helmholtz Zentrum München seeks to develop personalized medicine for the diagnosis, treatment and prevention of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The main office of the Center is located in Neuherberg to the north of Munich. Helmholtz Zentrum München has around 2,200 employees and is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with approximately 34,000 staff members. Das Helmholtz Zentrum München ist Partner im Deutschen Zentrum für Diabetesforschung e.V.